Skip to main content

Peer Review reports

From: ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer

Original Submission
2 Sep 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
20 Feb 2015 Editorially accepted
4 Mar 2015 Article published 10.1186/s12885-015-1108-1

You can find further information about peer review here.

Back to article page